Abstract:Senescence refers to a cellular state featuring a stable cell‐cycle arrest triggered in response to stress. This response also involves other distinct morphological and intracellular changes including alterations in gene expression and epigenetic modifications, elevated macromolecular damage, metabolism deregulation, and a complex proinflammatory secretory phenotype. The initial demonstration of oncogene‐induced senescence in vitro established senescence as an important tumour suppressive mechanism, in addition to apoptosis. Senescence not only halts the proliferation of premalignant cells but also facilitates the clearance of affected cells through immunosurveillance. Failure to clear senescent cells owing to deficient immunosurveillance may, however, lead to a state of chronic inflammation that nurtures a pro‐tumorigenic microenvironment favouring cancer initiation, migration, and metastasis. In addition, senescence is a response to post‐therapy genotoxic stress. Therefore, tracking the emergence of senescent cells becomes pivotal to detect potential pro‐tumorigenic events. Current protocols for the in vivo detection of senescence require the analysis of fixed or deep‐frozen tissues, despite a significant clinical need for real‐time bioimaging methods. Accuracy and efficiency of senescence detection is further hampered by a lack of universal and more specific senescence biomarkers. Recently, in an attempt to overcome these hurdles, an assortment of detection tools have been developed. These strategies all have significant potential for clinical utilization, and include flow cytometry combined with histo‐ or cytochemical approaches, nanoparticle‐based targeted delivery of imaging contrast agents, OFF‐ON fluorescent senoprobes, positron emission tomography (PET) senoprobes, and analysis of circulating SASP factors, extracellular vesicles, and cell‐free nucleic acids isolated from plasma. Here we highlight the occurrence of senescence in neoplasia and advanced tumours, assess the impact of senescence on tumorigenesis, and discuss how the ongoing development of senescence detection tools might improve early detection of multiple cancers and response to therapy in the near future.

Simple Detection Methods for Senescent Cells: Opportunities and Challenges

Cellular senescence in cancer: from mechanisms to detection

SenNet recommendations for detecting senescent cells in different tissues

Cellular Senescence: Defining a Path Forward

Recent Advances in Strategies for Imaging Detection and Intervention of Cellular Senescence

Recent Developments in Small-Molecule Fluorescent Probes for Cellular Senescence

Senescence in cancer: Advances in detection and treatment modalities

Chemical Strategies for the Detection and Elimination of Senescent Cells

Identification of senescent cells in multipotent mesenchymal stromal cell cultures: Current methods and future directions

Cellular aging beyond cellular senescence: Markers of senescence prior to cell cycle arrest in vitro and in vivo

Detection of senescence using machine learning algorithms based on nuclear features

Guidelines for minimal information on cellular senescence experimentation in vivo

Detecting senescence: a new method for an old pigment

Cellular senescence in ageing: from mechanisms to therapeutic opportunities

Cellular Senescence: Mechanisms and Therapeutic Potential

Quantitative identification of senescent cells in aging and disease

Molecular tools for analysing in vivo senescence

Yearning for machine learning: applications for the classification and characterisation of senescence

Methods for detection of mitochondrial reactive oxygen species in senescent cells

Senescence detection using reflected light

Targeting Senescent Cells for a Healthier Longevity: the Roadmap for an Era of Global Aging